The strength of the Therapeutics Development Network Coordinating Center lies in our unparalleled experience in setting up and managing cystic fibrosis studies and our intimate knowledge of the CF research community.
Site Search
To address the unique and emerging needs of people with cystic fibrosis, the Cystic Fibrosis Foundation has established a research working group to identify knowledge gaps, determine research priorities, and develop the infrastructure needed to conduct the research related to sexual, reproductive, and gender health.
The primary responsibility of the independent Data
Effective clinical development plans and good study design can save sponsors and investigators time and money, leading to faster development of potential new therapies for people with cystic fibrosis.
The Therapeutics Development Network includes over 90
Therapeutics Development Network investigators and research staff work every day to promote quality,
Access to antimicrobial tools can aid researchers in the discovery of new anti-infective treatments for cystic fibrosis.
Cystic fibrosis biological samples are available to qualified researchers to help develop promising new studies that will support CF research and aid in drug development and drug discovery.
The CFTR Antibodies Distribution Program works to streamline access to reagents specific for the detection of cystic fibrosis transmembrane conductance regulator (CFTR) expression.